DXC Technology (DXC) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
12 Apr, 2026Executive summary
Q3 FY26 revenue was $3.2 billion, down 1.0% year-over-year (down 4.3% organically), with adjusted EBIT margin at 8.2% and non-GAAP EPS at $0.96, outperforming guidance.
The company is executing a dual-track strategy: stabilizing legacy businesses and investing in AI-native, high-growth segments, with a refreshed brand and centralized sales enablement.
Fast-Track and AI-driven initiatives are ahead of schedule, targeting high-margin, repeatable offerings and expanding growth opportunities.
Strategic partnerships, especially in digital assets and payments, are expanding reach and enabling scalable solutions.
Notable new client wins and internal AI deployment are enhancing productivity and product development.
Financial highlights
Q3 revenue was $3.2 billion, down 4.3% organically year-over-year, with adjusted EBIT margin at 8.2% and non-GAAP EPS at $0.96.
Free cash flow for Q3 was $266 million; year-to-date $603 million, on track for $650 million full-year.
Book-to-bill ratio for Q3 was 1.12; trailing 12-month at 1.02, fourth consecutive quarter above one.
Net debt reduced by ~$970 million since start of FY25; total debt now ~$3.6 billion.
Share repurchases totaled $190 million year-to-date, with $65 million in Q3.
Outlook and guidance
Q4 organic revenue expected to decline 4%-5%; adjusted EBIT margin for Q4 guided at 6.5%-7.5%; non-GAAP EPS $0.65-$0.75.
Full-year FY26 guidance: organic revenue decline ~4.3%, adjusted EBIT margin ~7.5%, non-GAAP EPS ~$3.15, free cash flow ~$650 million.
FY27 capital allocation: $400 million to retire bonds, $250 million share repurchase in H1.
No quarterly dividends planned for fiscal 2026 to maintain flexibility.
Latest events from DXC Technology
- Operational turnaround and AI-driven innovation are expanding market reach and boosting valuation potential.DXC
Morgan Stanley Technology, Media & Telecom Conference 20262 Mar 2026 - Non-GAAP EPS up 17% and free cash flow guidance raised despite revenue decline.DXC
Q1 20251 Feb 2026 - Adjusted EBIT margin and non-GAAP EPS rose despite a 5.7% revenue decline.DXC
Q2 202515 Jan 2026 - Turnaround advances with new leadership, operational focus, and GenAI-driven efficiency gains.DXC
J.P. Morgan Ultimate Services Investor Conference 202413 Jan 2026 - Adjusted EBIT margin rose to 8.9% as revenue declined, with bookings and cash flow improving.DXC
Q3 20259 Jan 2026 - Annual meeting to vote on directors, auditor, executive pay, and director incentive plan shares.DXC
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, auditor, and pay, with strong governance and ESG focus.DXC
Proxy Filing1 Dec 2025 - Board elections, auditor ratification, and incentive plan share increase up for vote.DXC
Proxy Filing1 Dec 2025 - Key votes include board elections, auditor ratification, and executive pay approval.DXC
Proxy Filing1 Dec 2025